Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chugai Pharmaceutica ADR (CHGCY)

Chugai Pharmaceutica ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chugai Pharmaceutica ADR Nihonbashi Mitsui Tower 15th Floor 1-1 Nihonbashi-Muromachi 2-chome Chuo-ku Tokyo M0 103-8324 JPN

www.chugai-pharm.co.jp Employees: 7,604 P: 813-3281-6611

Description:

CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.

Key Statistics

Overview:

Market Capitalization, $K 67,378,792
Enterprise Value, $K 64,122,200
Shares Outstanding, K 3,289,980
Annual Sales, $ 7,891 M
Annual Net Income, $ 2,311 M
Last Quarter Sales, $ 2,122 M
Last Quarter Net Income, $ 735,900 K
EBIT, $ 669,150 K
EBITDA, $ 3,343 M
60-Month Beta 0.89
% of Institutional Shareholders 0.01%
Float, K 3,289,980
% Float 100.00%
Short Volume Ratio 0.33

Growth:

1-Year Return 28.03%
3-Year Return 21.83%
5-Year Return 41.99%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.22 on 10/25/24
Next Earnings Date 10/29/24
Earnings Per Share ttm 0.78
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Rate, $ 0.19
Annual Dividend Yield 0.90%
Most Recent Dividend 0.096 on 06/26/24
Next Ex-Dividends Date 06/26/24
Dividend Payable Date 09/22/14
Dividend Payout Ratio 23.62%
Most Recent Split 12-1 on 07/06/20

CHGCY Ratios

Ratio
Price/Earnings ttm 26.62
Price/Earnings forward 26.61
Price/Earnings to Growth N/A
Return-on-Equity % 22.30%
Return-on-Assets % 19.15%
Profit Margin % 29.29%
Debt/Equity 0.00
Price/Sales 8.88
Price/Cash Flow 26.82
Price/Book 6.21
Book Value/Share 0.00
Interest Coverage 16,585.89

CHGCY Dividends

Date Value
06/26/24 $0.0960
06/28/23 $0.0980
06/28/22 $0.1120
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar